New Balance is suing Steve Madden for deliberately copying its patent-protected 327 model sneaker in an attempt to piggyback on the commercial and critical success of the 327 design.
The US District Court for the District of Massachusetts received the complaint.
New Balance claims that Steve Madden created the Chasen model particularly to profit from New Balance's success with the 327.
New Balance claims it has sold several million pairs of the 327 since the sneaker first hit the market back in 2020.
In 2021, Steve Madden introduced the Chasen model, which New Balance claims not only slavishly copied the design of their 327 model shoe, including the distinctive outer sole design, but also used two diagonal downward stripes that copied the placement and appearance of New Balance's famous 'N' mark on both sides.
New Balance argues that Steve Madden also made a Chasen sneaker with "SM NY90" instead of the two stripes on the side, but that it still infringes on New Balance's design patents for the 327 footwear's sole.


Trump’s U.S. Open Visit Delays Final, Fans Face Long Security Lines
Iran Closes Strait of Hormuz Again After Brief Reopening, Rattling Global Energy Markets
Why have so few atrocities ever been recognised as genocide?
Trump Plans UFC Event at White House for America’s 250th Anniversary
Uranium Bull Market Gains Momentum Amid Supply Deficits and Geopolitical Tensions
Australia Extends Fuel Sulphur Relaxation Amid Iran War Supply Disruptions
Apple Wins ITC Ruling, Keeping Blood-Oxygen Feature on Apple Watch
Eli Lilly in Talks to Acquire Kelonia Therapeutics for Over $2 Billion
Trump Set to Announce Washington D.C. as Host of 2027 NFL Draft
Trump Urges Hall of Fame Induction for Roger Clemens Amid Renewed Debate
KOSPI Hits Record High as AI Chip Demand Lifts SK Hynix and Samsung Stocks
Trump to Host UFC Event at White House on His 80th Birthday
Oil Prices Slip as U.S.-Iran Tensions and Ceasefire Uncertainty Weigh on Markets
Trump Signs Executive Order Targeting Big-Money College Athlete Payouts
Abbott Laboratories Ordered to Pay $53 Million in Premature Infant Formula Lawsuit 



